Estr-4-en-3,17-dion

(+)-Estr-4-ene-3,17-dione

HCID 92834CAS 734-32-7

Grundinformationen

Standard-SMILES
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CCC2=O
InChIKey
JRIZOGLBRPZBLQ-QXUSFIETSA-N
Summenformel
C18H24O2
Durchschnittliche Molmasse
272,4 g/mol
Monoisotopische Masse
272,17763001

Überblick

19-Norandrostenedione is a 3-oxo steroid.

Namen und Bezeichner

Bevorzugter Name
(+)-Estr-4-ene-3,17-dione
IUPAC
(8R,9S,10R,13S,14S)-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione
Lokaler Name
Estr-4-en-3,17-dion
Englischer Name
Norandrostenedione
Summenformel
C18H24O2
Molmasse
272.38

Namen und Synonyme

19-Norandrostenedione734-32-719-Norandrost-4-ene-3,17-dione19-nor-4-androstene-3,17-dioneNordionedelta4-Estrene-3,17-dionedelta,4-Estrene-3,17-dioneU90987PVU5(+)-Estr-4-ene-3,17-dioneNSC-12164DTXSID5086239219-nor-A-dione
Weitere Namen anzeigen
BolandioneESTRENONE19-demethyl-4-androstenedioneNSC 121644-ESTREN-3,17-DIONE
RefChem:79523DTXCID601334157(1S,2R,10R,11S,15S)-15-methyltetracyclo(8.7.0.02,?.011,1?)heptadec-6-ene-5,14-dione211-995-8NorandrostenedioneEstr-4-ene-3,17-dione(+)-19-Norandrost-4-ene-3,17-dione19-Nor-4-androstenedione

Datenbank-Bezeichner

CAS
734-32-7
PubChem CID
92834
DTXSID
DTXSID50862392
ChEBI
CHEBI:34187
UNII
U90987PVU5
EC Number
211-995-8
Nikkaji
J38.938B

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,5
Polarare Oberfläche (TPSA)
34,1 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
0
Schwere Atome
20

Experimentelle und physikochemische Eigenschaften

Drugs · 4 Einträge

DEA NFLIS-Drug Category -> Steroids

DEA NFLIS-Drug Category -> Steroids

DEA Schedule III Controlled Substance -> Anabolic steroids

Pharmaceuticals -> Listed in ZINC15

Endocrine DisruptorsPotential endocrine disrupting compound

Physikochemische Eigenschaften

Schmelzpunkt
169 · 169-172°C
Siedepunkt
433.4 · 433.4±45.0 °C(Predicted)
Dichte
1.13 · 1.13±0.1 g/cm3(Predicted)
Dampfdruck
0.001 Pa · 0.001Pa at 25℃
storage temp.
Refrigerator
Löslichkeit
25 mg/ml; · DMF: 25 mg/ml; DMSO: 15 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/ml; Ethanol: 10 mg/ml

Sicherheit und Regulatorisches

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P273, P280, P301+P317, P302+P352, P317, P318, P321, P330, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 15 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 2 Einträge

DEA schedule III controlled substance

Status: Active Update: 09-01-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/18736

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Sicherheitsdaten

wgk
3
hs_code
29372900
risk_code
11-34
hazard_code
F,C
safety_code
16-26-36/37/39-45

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 1 Eintrag

19-Norandrostenedione may be metabolized to 19-nortestosterone in both men and women. 19-Norandrostenedione, also known as nandrolone, is the basic substance of some very popular injectable anabolic steroids, however 19-norandrostenedione is not metabolized to testosterone. Whether or not increases in 19-nortestosterone levels would be sustained long enough by taking 19-norandrostenedione to show an increase in nitrogen retention and muscle strength and mass is unknown. 19-Norandrostenedione has also been shown to bind to androgen receptors with high selectivity. Transactivation of androgen receptor dependent reporter gene expression was 10 times lower than that produced by dihydrotestosterone. [1]

Metabolism/MetabolitesSpecific metabolites of 19-nor-5-androstene-3, 17-dione are 19-nordehydroandrosterone and 19-nordehydroepiandrosterone.
Absorption, Distribution and ExcretionAbsorption appears variable, but some absorption does occur.

Anwendungen

VerwendenNorethindrone intermediate

Anbieter50 Anbieter

湖北威德利化学试剂有限公司181-6332-1995 18062128043 · [email protected]
艾吉析科技(上海)有限公司17717235263 · [email protected]
山东海舟生物工程有限公司130-0567-0367 13006570367 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
陕西帕尼尔生物科技有限公司029-84385017-8003 13259417953 · [email protected]

Zugehörige Reaktionen

18

Verknüpfte Notizen

Wird geladen…